Rendering

Component: (Network and Table)
Network
033 - Disclosure - Note 12 - Equity Incentive Plan (Tables)
(http://www.anikatherapeutics.com/20161231/role/statement-note-12-equity-incentive-plan-tables)
TableStatement [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000898437 (http://www.sec.gov/CIK)
Scenario [Axis]Scenario, Unspecified [Domain]
Statement [Line Items]Period [Axis]
2016-01-01 - 2016-12-31
Notes Tables
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
    December 31,
    2016   2015   2014
Risk free interest rate  
0.94%
-
1.55%
  
1.15%
-
1.46%
  
1.16%
-
1.39%
Expected volatility  
47.33%
-
51.61%
  
53.15%
-
54.65%
  
53.28%
-
57.05%
Expected life (years)  
 
4.5
 
  
 
4.5
 
  
 
4.0
 
Expected dividend yield  
 
0.00%
 
  
 
0.00%
 
  
 
0.00%
 
  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
    December 31,
    2016   2015   2014
Cost of product revenue   $
148
     $
42
     $
61
  
Research & development    
467
      
269
      
202
  
Selling, general & administrative    
2,777
      
1,914
      
1,344
  
Total stock-based compensation expense   $
3,392
     $
2,225
     $
1,607
  
  
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity [Table Text Block]
    2016   2015
    Number of
Shares		   Weighted
Average
Exercise
Price Per
Share		   Number of
Shares		   Weighted
Average
Exercise
Price Per
Share
Options and SAR's outstanding at beginning of year    
762,260
     $
18.75
      
851,287
     $
14.85
  
Granted    
354,275
     $
40.77
      
111,625
     $
39.25
  
Cancelled    
(58,841
 )   $
30.05
      
(85,349
 )   $
19.77
  
Expired    
(3,310
 )   $
11.37
      
(8,825
 )   $
20.03
  
Exercised    
(74,815
 )   $
15.46
      
(106,478
 )   $
10.96
  
Stock options and SAR's outstanding at end of year    
979,569
     $
26.15
      
762,260
     $
18.75
  
  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
    2016   2015
    Number of
Shares		   Weighted
Average
Grant Date
Fair Value		   Number of
Shares		   Weighted
Average
Grant Date
Fair Value
Nonvested at Beginning of year    
150,384
     $
34.29
      
109,614
     $
23.91
  
Granted    
87,158
     $
38.11
      
81,080
     $
37.84
  
Cancelled    
(4,950
 )   $
36.20
      
(10,635
 )   $
32.02
  
Expired    
-
     $
-
      
-
     $
-
  
Vested/Released    
(25,515
 )   $
33.35
      
(29,675
 )   $
19.31
  
Nonvested at end of year    
207,077
     $
36.44
      
150,384
     $
34.29